lmost forty years ago, it was first hypothesized that an increased dietary intake of omega-3 polyunsaturated fatty acids (PUFA) from fish fat could exert protective effects against several pathologies. Decades of intense preclinical investigation have supported this hypothesis in a variety of model systems. Several clinical cardiovascular studies demonstrated the beneficial health effects of omega-3 PUFA, leading medical institutions worldwide to publish recommendations for their increased intake. However, particularly in recent years, contradictory results have been obtained in human studies focusing on cardiovascular disease and the clinical evidence in other diseases, particularly chronic inflammatory and neoplastic diseases, was never established to a degree that led to clear approval of treatment with omega-3 PUFA. Recent data not in line with the previous findings have sparked a debate on the health efficacy of omega-3 PUFA and the usefulness of increasing their intake for the prevention of a number of pathologies. In this review, we aim to examine the controversies on the possible use of these fatty acids as preventive/curative tools against the development of cardiovascular, metabolic, and inflammatory diseases, as well as several kinds of cancer.

Weylandt, K., Serini, S., Chen, Y., Su, H. M., Lim, K., Cittadini, A., Calviello, G., Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence., <<BIOMED RESEARCH INTERNATIONAL>>, 2015; 2015 (2015): 143109-N/A. [doi:10.1155/2015/143109] [http://hdl.handle.net/10807/70086]

Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence.

Serini, Simona;Cittadini, Achille;Calviello, Gabriella
2015

Abstract

lmost forty years ago, it was first hypothesized that an increased dietary intake of omega-3 polyunsaturated fatty acids (PUFA) from fish fat could exert protective effects against several pathologies. Decades of intense preclinical investigation have supported this hypothesis in a variety of model systems. Several clinical cardiovascular studies demonstrated the beneficial health effects of omega-3 PUFA, leading medical institutions worldwide to publish recommendations for their increased intake. However, particularly in recent years, contradictory results have been obtained in human studies focusing on cardiovascular disease and the clinical evidence in other diseases, particularly chronic inflammatory and neoplastic diseases, was never established to a degree that led to clear approval of treatment with omega-3 PUFA. Recent data not in line with the previous findings have sparked a debate on the health efficacy of omega-3 PUFA and the usefulness of increasing their intake for the prevention of a number of pathologies. In this review, we aim to examine the controversies on the possible use of these fatty acids as preventive/curative tools against the development of cardiovascular, metabolic, and inflammatory diseases, as well as several kinds of cancer.
2015
Inglese
Weylandt, K., Serini, S., Chen, Y., Su, H. M., Lim, K., Cittadini, A., Calviello, G., Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence., <<BIOMED RESEARCH INTERNATIONAL>>, 2015; 2015 (2015): 143109-N/A. [doi:10.1155/2015/143109] [http://hdl.handle.net/10807/70086]
File in questo prodotto:
File Dimensione Formato  
70086OA.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.37 MB
Formato Adobe PDF
1.37 MB Adobe PDF Visualizza/Apri
Weylandt et al., BioMed Res Int., 2015.pdf

non disponibili

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 1.32 MB
Formato Unknown
1.32 MB Unknown   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/70086
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 82
  • ???jsp.display-item.citation.isi??? 50
social impact